Sick of corporate greed

The scandal of expensive medicines

In spite of advances in medical innovation, millions of people around the world suffer and die from treatable conditions because medicines are too expensive.
Historically this has tragically affected low and middle-income countries. But in recent years, the NHS has also struggled to pay extortionate prices and has had to turn down or ration new medicines. 
 

Corporate profits trump public health

Why are medicines so expensive? Drug companies can charge runaway prices because new drugs are protected by legal monopolies. This profit-driven model has made the pharmaceutical industry the most profitable in the world. Drug companies justify high prices by claiming they need to recoup their research and development costs. But nine of the top ten pharmaceutical companies spend more on marketing than on research and development. Also, most early-stage innovative research is publically funded. Drug companies often buy up taxpayer funded research and reap the profits from charging extortionate prices while patients are denied access to vital medicines.

Join the fight for affordable medicines

We’ve joined forces with Missing Medicines – a coalition of UK organisations fighting for affordable medicines globally. We want conditions on all public health research to make sure the medicines developed are affordable and accessible here in the UK and across the world.

Latest Blog Posts

Our NHS at 70 is still amazing. Why isn't there an NHS for the world?


05 July 2018

The National Health Service turns 70 today. Despite too many years of austerity cuts, contracting out and PFIs, most of us still feel the NHS is one of the defining achievements of our society.

Trump: “put American patients first” … but er, after big business


30 May 2018

The Trump administration has promised to use American muscle in trade negotiations to force health services, including the NHS, to pay much more for drugs to American corporations. They are putting big business first, not patients.

Five reasons Sturgeon should stand up to Big Pharma


24 May 2018

The high price of breast cancer drug Perjeta means it is not currently available to patients in Scotland, but is available in England and Wales. How do we make sure essential medicines are affordable for everyone in the UK?